OLD Mission Capital LLC Takes Position in YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY)

OLD Mission Capital LLC acquired a new position in shares of YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNYFree Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 29,558 shares of the company’s stock, valued at approximately $155,000. OLD Mission Capital LLC owned 2.22% of YieldMax MRNA Option Income Strategy ETF as of its most recent SEC filing.

YieldMax MRNA Option Income Strategy ETF Price Performance

NYSEARCA MRNY opened at $2.44 on Wednesday. YieldMax MRNA Option Income Strategy ETF has a 12 month low of $2.31 and a 12 month high of $22.37. The stock has a 50 day moving average of $3.35 and a 200-day moving average of $5.10.

About YieldMax MRNA Option Income Strategy ETF

(Free Report)

The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options.

See Also

Want to see what other hedge funds are holding MRNY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNYFree Report).

Receive News & Ratings for YieldMax MRNA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YieldMax MRNA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.